The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global generic oncology drugs market is expected to grow from $23.79 billion in 2022 to $25.64 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The generic oncology drugs market is expected to reach $33.18 billion in 2027 at a CAGR of 6.7%.

North America held the largest generic oncology drugs market share.

Generic Oncology Drugs Market Driver
A significant rise in cancer patients is expected to propel the growth of the generic oncology drugs market going forward. Cancer refers to uncontrolled cell growth, which impacts various organs and contributes to significant morbidity and mortality worldwide. The availability of cost-effective generic oncology drugs plays a crucial role in cancer treatment by increasing access to essential therapies, promoting market competition, and reducing healthcare costs. For instance, in January 2022, according to the National Cancer Institute (NCI), a US-based government agency, in the United States, approximately 5.4% of the population, or 18.1 million individuals, were cancer survivors. In addition, 623,405 people were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma in 2022, projected to rise to 693,452 by 2025. Therefore, the significant rise in cancer patients is driving the growth of the generic oncology drugs market.

View More On The Generic Oncology Drugs Market Report 2023 – https://www.thebusinessresearchcompany.com/report/generic-oncology-drugs-global-market-report

Prominent Generic Oncology Drugs Market Trend
Novel formulations are a key trend gaining popularity in the generic oncology drugs market. Major companies operating in the generic oncology drugs market are focused on developing novel drug delivery systems, modified-release formulations, and alternative dosage forms to improve patient compliance and sustain their position in the market. For instance, in January 2023, MSN Laboratories Private Limited, an India-based pharmaceutical company specializing in generic drugs, launched Palborest, the world’s first generic Palbociclib tablets for advanced breast cancer treatment. It is a generic breast cancer drug that offers a cost-effective alternative to the innovator tablet while maintaining bioequivalence. Its tablet dosage form provides a notable advantage over capsules as it can be taken with or without food and co-administered with proton pump inhibitors or antacids. Furthermore, the tablet formulation is free from lactose and gelatin, enhancing the drug’s efficacy.

Generic Oncology Drugs Market Prominent Players
Major players in the generic oncology drugs market are Pfizer Inc., AbbVie, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Fresenius Kabi AG, GlaxoSmithKline PLC, Eli Lilly and Company, Merck & Co. Inc., Becton Dickinson and Company, Baxter International Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Hikma Pharmaceuticals, Endo Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Lupin Limited, Towa Pharmaceutical Co Ltd, Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., and Accord Healthcare.

Request A Sample Of The Global Generic Oncology Drugs Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12174&type=smp

Key Generic Oncology Drugs Market Segments
The global generic oncology drugs market is segmented –
1) By Molecule Type: Large Molecule, Small Molecule
2) By Route of Administration: Oral, Parenteral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Managed Care Institutions

The Generic Oncology Drugs Global Market Report 2023  provides a comprehensive overview on the generic oncology drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the generic oncology drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Generic Pharmaceuticals Global Market Report 2023
Drugs For Immunotherapy Global Market Report 2023
Oncology Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model